Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Penfornis

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
Pharmaceutics|July 29, 2023
Impact of Intensive Glycemic Treatment on Diabetes Complications-A Systematic ReviewJuliana Poonoosamy, Philippe Lopes, Priscille Huret, et al.
Diabetes & Metabolism|December 18, 2025
Is Omnipod 5 cost effective for the management of type 1 diabetes among adults in France?Jean-Pierre Riveline, Colin Hopley, Anamaria-Vera Olivieri, et al.
Diabetes Care|January 12, 2021
Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-upCoralie Amadou, Sylvia Franc, Pierre-Yves Benhamou, et al.
Medicina (Kaunas, Lithuania)|December 23, 2022
Delayed Diagnosis of Bilateral Neuroarthropathy: Serious Impact on the Development of Charcot's Foot, a Case ReportTatiana Benard, Corinne Lequint, Anne Christine Jugnet, et al.
Advances in Therapy|February 1, 2017
Effectiveness and Persistence of Liraglutide Treatment Among Patients with Type 2 Diabetes Treated in Primary Care and Specialist Settings: A Subgroup Analysis from the EVIDENCE Study, a Prospective, 2-Year Follow-up, Observational, Post-Marketing StudyLuc Martinez, Alfred Penfornis, Jean-Francois Gautier, et al.
The Journal of Clinical Endocrinology and Metabolism|March 25, 2011
Endogenous chronic hyperinsulinemia does not increase the production rate of VLDL apolipoprotein B: proof from a kinetic study in patients with insulinomaLaurence Duvillard, Emmanuel Florentin, Frédéric Pont, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 3, 2013
Chronic hyperinsulinemia does not increase the production rate of high-density lipoprotein apolipoprotein AI: evidence from a kinetic study in patients with insulinomaLaurence Duvillard, Emmanuel Florentin, Frédéric Pont, et al.
Neuromodulation : Journal of the International Neuromodulation Society|August 11, 2017
Gastrointestinal Peptides During Chronic Gastric Electrical Stimulation in Patients With Intractable VomitingMathieu Meleine, Chloé Melchior, Philip Prinz, et al.
Diabetes Research and Clinical Practice|November 28, 2025
Chat, Gemini and Claude at the dinner table: assessing general-purpose AI tools for carbohydrate counting in the context of type 1 diabetesSandra Goncalves, Céline Coelho, Lysiane Pretre, et al.
Advances in Therapy|October 2, 2015
Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice--EVIDENCE: A Prospective, 2-Year Follow-Up, Observational, Post-Marketing StudyJean-Francois Gautier, Luc Martinez, Alfred Penfornis, et al.
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Pharmaceutics|July 29, 2023
Impact of Intensive Glycemic Treatment on Diabetes Complications-A Systematic ReviewJuliana Poonoosamy, Philippe Lopes, Priscille Huret, et al.
Diabetes & Metabolism|December 18, 2025
Is Omnipod 5 cost effective for the management of type 1 diabetes among adults in France?Jean-Pierre Riveline, Colin Hopley, Anamaria-Vera Olivieri, et al.
Diabetes Care|January 12, 2021
Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-upCoralie Amadou, Sylvia Franc, Pierre-Yves Benhamou, et al.
Medicina (Kaunas, Lithuania)|December 23, 2022
Delayed Diagnosis of Bilateral Neuroarthropathy: Serious Impact on the Development of Charcot's Foot, a Case ReportTatiana Benard, Corinne Lequint, Anne Christine Jugnet, et al.
Advances in Therapy|February 1, 2017
Effectiveness and Persistence of Liraglutide Treatment Among Patients with Type 2 Diabetes Treated in Primary Care and Specialist Settings: A Subgroup Analysis from the EVIDENCE Study, a Prospective, 2-Year Follow-up, Observational, Post-Marketing StudyLuc Martinez, Alfred Penfornis, Jean-Francois Gautier, et al.
The Journal of Clinical Endocrinology and Metabolism|March 25, 2011
Endogenous chronic hyperinsulinemia does not increase the production rate of VLDL apolipoprotein B: proof from a kinetic study in patients with insulinomaLaurence Duvillard, Emmanuel Florentin, Frédéric Pont, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 3, 2013
Chronic hyperinsulinemia does not increase the production rate of high-density lipoprotein apolipoprotein AI: evidence from a kinetic study in patients with insulinomaLaurence Duvillard, Emmanuel Florentin, Frédéric Pont, et al.
Neuromodulation : Journal of the International Neuromodulation Society|August 11, 2017
Gastrointestinal Peptides During Chronic Gastric Electrical Stimulation in Patients With Intractable VomitingMathieu Meleine, Chloé Melchior, Philip Prinz, et al.
Diabetes Research and Clinical Practice|November 28, 2025
Chat, Gemini and Claude at the dinner table: assessing general-purpose AI tools for carbohydrate counting in the context of type 1 diabetesSandra Goncalves, Céline Coelho, Lysiane Pretre, et al.
Advances in Therapy|October 2, 2015
Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice--EVIDENCE: A Prospective, 2-Year Follow-Up, Observational, Post-Marketing StudyJean-Francois Gautier, Luc Martinez, Alfred Penfornis, et al.
Pageof 12